{
  "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
  "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
  "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
  "authorId": "neumora-therapeutics",
  "authorName": "Neumora Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2023-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 13,
  "pageCount": 32,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Includes a timeline diagram for the randomized, double-blind treatment phase and a summary table of inclusion criteria and endpoints.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/13",
  "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
  "deckJsonHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507.json",
  "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.6,
        "x": 0.36,
        "y": 0.18
      },
      "kind": "diagram",
      "text": "Pivotal Efficacy Studies timeline showing screening, randomization, treatment, and OLE enrollment",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c39c002-6479-491f-a7fe-b906c310de28",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.36,
        "y": 0.91
      },
      "kind": "disclaimer",
      "text": "Safety Assessments include Change in Sexual Functioning Questionnaire (CSFQ-14). CGI-I = Clinical Global Impression-Improvement scale; CGI-S = Clinical Global Impression-Severity scale; EQ-5D 5L = EuroQol-5D 5L; HAM-A = Hamilton Anxiety Rating Scale; MADRS = Montgomery-Åsberg Depression Rating Scale; MDD = major depressive disorder; PHQ-9 = Patient Health Questionnaire-9; QD = once daily; SDS = Sheehan Disability Scale; SHAPS = Snaith-Hamilton Pleasure Scale; wk = week; WPAI-GH = Work Productivity and Activity Impairment Questionnaire – General Health.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36ee4959-52dd-4aac-8a9d-114c5fd84e24",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.29,
        "x": 0.04,
        "y": 0.24
      },
      "kind": "list",
      "text": "KOASTAL-1: Planned 3Q23 Initiation; KOASTAL-2: Planned 1Q24 Initiation; KOASTAL-3: Planned 4Q23 Initiation; KOASTAL-LT: Planned 2H23 Initiation",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "695085b3-630c-4eda-b2a3-192b98310f09",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.6,
        "x": 0.36,
        "y": 0.6
      },
      "kind": "table",
      "text": "KOASTAL-1, KOASTAL-2, KOASTAL-3 Summary table of inclusion criteria and endpoints",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "68252ac5-3534-4989-b804-594b628f3d04",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.96,
        "x": 0.02,
        "y": 0.02
      },
      "kind": "title",
      "text": "Pivotal Studies Designed to Evaluate Potential Benefits of Navacaprant Monotherapy in MDD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc174ef1-3b15-4f4a-872c-42955143e1a3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "402f46f0-bd79-4d5e-81f3-5201546b3df3",
      "evidence": "table/data: KOASTAL-1, KOASTAL-2, KOASTAL-3 Summary table of inclusion criteria and endpoints",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "bc79270f-2b31-439e-a92b-fbb1dcd0264a",
      "evidence": "Standardized representation of RCT phases, endpoints, and inclusion criteria.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}